Pembrolizumab-induced Myasthenia Gravis Relapse After Immunosuppressive Therapy. Oshima Y, Fujii S, Horiuchi K. Intern Med 2022 Apr 9. doi: 10.2169/internalmedicine.8554.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oshima Y, Fujii S, Horiuchi K. Pembrolizumab-induced Myasthenia Gravis Relapse After Immunosuppressive Therapy. Intern Med 2022 Apr 9. doi: 10.2169/internalmedicine.8554.
PMID: 35400705